Veracyte, Inc. Common Stock Issued for the Trailing 12 Months (TTM) ending March 31, 2025: USD -2.97 M

Veracyte, Inc. Common Stock Issued is USD -2.97 M for the Trailing 12 Months (TTM) ending March 31, 2025, a -134.58% change year over year. Common stock issued is cash received from issuing new shares of the company’s common stock.
  • Veracyte, Inc. Common Stock Issued for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 8.58 M, a -40.80% change year over year.
  • Veracyte, Inc. Common Stock Issued for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 14.50 M, a 30.64% change year over year.
  • Veracyte, Inc. Common Stock Issued for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 11.10 M, a -98.13% change year over year.
  • Veracyte, Inc. Common Stock Issued for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 593.82 M, a 330.78% change year over year.
Key Data
Date Common Stock Issued Common Stock Repurchased Free Cash Flow Operating Cash Flow